SDI Limited (ASX:SDI)
Australia · Delayed Price · Currency is AUD 0.9200
+0.0050 (0.55%)
Feb 11, 2026, 10:33 AM AEST
SDI Limited Revenue
In the fiscal year ending June 30, 2025, SDI Limited had annual revenue of 110.38M AUD, down -0.74%. SDI Limited had revenue of 58.84M in the half year ending June 30, 2025, with 2.58% growth.
Revenue
110.38M
Revenue Growth
-0.74%
P/S Ratio
0.99
Revenue / Employee
n/a
Employees
n/a
Market Cap
108.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 110.38M | -822.00K | -0.74% |
| Jun 30, 2024 | 111.21M | 3.35M | 3.11% |
| Jun 30, 2023 | 107.86M | 12.70M | 13.35% |
| Jun 30, 2022 | 95.15M | 13.50M | 16.54% |
| Jun 30, 2021 | 81.65M | 14.27M | 21.18% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Sigma Healthcare | 6.00B |
| Cochlear | 2.34B |
| Pro Medicus | 212.98M |
| Trajan Group Holdings | 166.46M |
| Austco Healthcare | 81.41M |
| Cyclopharm | 30.72M |
| Alterity Therapeutics | 5.44M |
SDI Limited News
- 2 months ago - SDI Limited (SDLDF) Shareholder/Analyst Call Transcript - Seeking Alpha
- 1 year ago - SDI Ltd (ASX:SDI) (Q1 2025) Earnings Call Highlights: Strong Margins and Market Growth Amid ... - GuruFocus